Last reviewed · How we verify
NCT01948648
Effects of Fish Oil and Colesevelam (STAIR7007)
NA trial testing Colesevelam in Sitosterolemia in 13 participants. Status unknown.
30 April 2021
Quick facts
| Lead sponsor | University of Manitoba |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 13 |
| Start date | 6 February 2018 |
| Primary completion | 30 April 2021 |
| Estimated completion | 30 July 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Colesevelam (COLESEVELAM) — full drug profile →
- Fish Oil — full drug profile →
- Combination of fish oil and colesevelam — full drug profile →
Conditions studied
- Sitosterolemia — all drugs for Sitosterolemia →
Sponsor
University of Manitoba
Who can join
8 and older, any sex, with Sitosterolemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
If treatment of colesevelam, fish oil in conjunction with ezetimibe, will lead to further reduction in plasma plant sterol levels in sitosterolemia patients. We hypothesize that treatments with fish oil, colesevelam and ezetimibe will maximize decrease in plasma concentrations of sitosterol and other plant sterols in sitosterolemia patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01948648
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Colesevelam
Trials testing the same drug.
- NCT06197763 — Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation. · Phase 1, PHASE2 · not yet recruiting
- NCT03955575 — Treatment of Bile Acid Malabsorption With Liraglutide · Phase 4 · completed
- NCT03270085 — Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption · Phase 2 · completed
- NCT02682680 — Randomized Trial Comparing Colesevelam vs. Ezetimibe · Phase 4 · completed
- NCT00715273 — Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication · Phase 4 · completed
Other University of Manitoba trials
Trials by the same sponsor.
- NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
- NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
- NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
- NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
- NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01948648 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
- Last refreshed: 10 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01948648.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing